Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 798 participants.

Also called NCT01422421

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 798 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01422421
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01422421. Randomized; double masking; primary purpose prevention. Start 2011-08 (registry gives no type); primary completion 2022-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease
Condition
Hypertension
Condition
Dyslipidemia
Intervention (Other)
intensive control
Intervention (Other)
standard control
Lead sponsor
Takeshi Morimoto (class: other)
Collaborator
University of the Ryukyus (class: other)

Record details

Record id
cardio:ct-nct01422421
Content hash
00a1497904e8104676c524def988af77a992312fa4cd482e2afebf46eb9c901c